Market Overview
The EPA and DHA supplements market encompasses products containing eicosapentaenoic acid and docosahexaenoic acid, the primary bioactive omega-3 fatty acids found in marine and algal sources. Valued at roughly $2.25 billion globally in 2025, the market serves consumers primarily through dietary supplement channels, with growing applications in functional foods and beverages. Products are available in various formats including softgels, liquids, and gummies, with fish oil remaining the dominant source type.
- •Market size estimated at approximately $2.25 billion in 2025 with steady year-over-year expansion
- •Dietary supplements remain the largest application segment, while functional foods and infant formula represent emerging growth areas
- •Product formats include softgels, liquids, gummies, and powders, with softgels commanding the majority of sales
Growth Drivers
Rising awareness of cardiovascular and cognitive health benefits associated with omega-3 fatty acids is a primary factor propelling market expansion. An aging global population, coupled with increasing prevalence of chronic conditions such as heart disease and cognitive decline, has amplified consumer demand for preventive nutrition. Growing clinical evidence supporting EPA and DHA supplementation, along with physician recommendations, continues to validate and expand the market's consumer base.
- •Growing elderly population and rising incidence of lifestyle diseases drive preventive supplement consumption
- •Increasing scientific validation and regulatory approvals for omega-3 health claims boost consumer confidence
- •Expanding vegan and vegetarian consumer segments drive demand for algae-based DHA and EPA alternatives
Segmentation and Regional Analysis
The market is segmented by source type, including fish oil, krill oil, cod liver oil, and algal oil, with fish oil currently representing the largest share by volume. By application, dietary supplements dominate, followed by pharmaceuticals and functional foods. Geographically, North America holds the largest market share, supported by high health consciousness and established supplement culture, while Europe maintains strong demand and the Asia-Pacific region shows accelerating growth driven by rising incomes and health awareness.
- •Fish oil leads source-based segmentation, while algal oil is the fastest-growing segment due to vegetarian and sustainability trends
- •North America accounts for the largest regional share, with Europe and Asia-Pacific representing significant and expanding markets
- •Infant formula and pharmaceutical applications are growing faster than traditional dietary supplement segments
Trends and Outlook
What are the recent trends and outlook?
The market is experiencing a notable shift toward algae-derived omega-3s as consumers seek vegetarian, vegan, and environmentally sustainable alternatives to traditional fish oil. High-concentration, high-purity formulations with reduced oxidation and improved organoleptic properties are gaining preference among informed consumers. E-commerce growth and direct-to-consumer models are reshaping distribution, while personalized nutrition and combination products pairing omega-3s with vitamins or other bioactive compounds represent emerging product strategies.
- •Sustainability concerns and vegan dietary trends accelerate adoption of algal oil as a premium omega-3 source
- •Concentrated and high-purity formulations with advanced delivery technologies are increasingly standard
- •Digital commerce and personalized supplement subscriptions are transforming how consumers discover and purchase omega-3 products
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.